Healthcare Policy

Overview

BakerHostetler’s Healthcare Policy team combines the efforts of experienced health law practitioners and policy professionals on behalf of clients seeking to resolve or avert public policy concerns through legislative or administrative action. We serve as partners and counselors for our clients as they navigate today’s complex and rapidly changing healthcare industry environment.

A Full Range of Capabilities

We approach our clients individually to craft a strategy for advocacy. This involves spending time with the client’s team to identify priorities, strengths, and issues of concern. Our team employs a strategy that engages members and staff from both sides of the political aisle and invites all interested parties to participate in crafting a legislative, regulatory, or administrative solution that both addresses the client’s concerns and adheres to sound principles of government policy. Policy achievements are accomplished through bipartisan advocacy efforts.

Our team develops strategic plans tailored to specific legislative and administrative goals. The team includes a former U.S. Ambassador, numerous former senior executive branch officials, and former Capitol Hill staff. Our extensive knowledge base and government contacts allow us to navigate the political waters in Washington, D.C., and beyond for healthcare industry clients interested in influencing the direction of change.

More »

Our team understands the core healthcare issues that drive our clients’ strategies, and we work seamlessly to provide health policy-focused services and solutions for a wide variety of clients, including:

  • Academic Medical Centers
  • Hospitals
  • Physician Groups
  • Home Health and Hospice Care
  • Dental Practices
  • Long-term Care Providers
  • Medical Device Companies
  • Pharmaceutical Manufacturers
  • Suppliers of Healthcare-related Goods
  • Trade Associations
  • Pharmacies
  • Dialysis Centers
  • Biologics and Cosmetics

Select Experience

  • Represent the nation’s leading pediatric hospital association in their efforts to develop special national network options in Medicaid policy for children with complex conditions; called the Advancing Care for Exceptional Kids Act of 2015 (HR 546/S 298), a bipartisan legislative initiative.
  • Represent hospitals in Texas and Washington State in challenging a CMS interpretation of the hospital-specific DSH reimbursement limit relative to the calculation of Medicaid shortfall.
  • Represent hospitals before Congress relating to Medicaid, CHIP, state-needed payments, and other government program reimbursement matters.
More »

Experience

  • Represent the nation’s leading pediatric hospital association in their efforts to develop special national network options in Medicaid policy for children with complex conditions; called the Advancing Care for Exceptional Kids Act of 2015 (HR 546/S 298), a bipartisan legislative initiative.
  • Represent hospitals in Texas and Washington State in challenging a CMS interpretation of the hospital-specific DSH reimbursement limit relative to the calculation of Medicaid shortfall.
  • Represent hospitals before Congress relating to Medicaid, CHIP, state-needed payments, and other government program reimbursement matters.
  • Routinely work with CMS, HRSA, CMM, and FDA to present client concerns, provide regulatory comments, and draft policy.
  • Advise pharmaceutical, medical device, and biologic manufacturers as well as private equity funds on recent FDA policy actions.
  • Represent clients in 340B and other reimbursement-related matters.

Recognition

  • Recognized as one of the top law firms for client service, we were named to the 2018 BTI Client Service 30 for the fourth consecutive year.

Blog

In The Blogs

Previous Next
Health Law Update
Proposed IPPS Rule Changes
May 15, 2018
The Centers for Medicare & Medicaid Services (CMS) recently released its proposed rules for the Hospital Inpatient Prospective Payment System (IPPS) for fiscal year (FY) 2019. As discussed below, the proposed rule focuses on promoting...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
May 14, 2018
LAWMAKERS PRAISE, CRITICIZE TRUMP PLAN ON DRUG PRICES On Capitol Hill, reaction to President Donald Trump’s “American Patients First” plan to bring down prescription drug prices fell predictably along partisan lines: Republicans generally...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
May 7, 2018
GOP LAWMAKERS: EUROPE, CANADA ‘FREE RIDING’ ON US DRUG INNOVATION More than two dozen House Republicans last week called on President Donald Trump to leverage upcoming trade negotiations to stop other nations from “free riding” on U.S...
Read More ->
Health Law Update
Capitol Hill Healthcare Update
April 23, 2018
AZAR ILLNESS DELAYS WHITE HOUSE ANNOUNCEMENT ON DRUG PRICING INITIATIVE Health & Human Services (HHS) Secretary Alex Azar is recovering at his home in Indianapolis following his second hospitalization in less than a week to treat a bowel...
Read More ->
Health Law Update
CMS aims to decrease burdens and increase innovation in Medicare parts C and D with new April 2018 guidance
By Charlene L. McGinty, Jeffrey R. Murray Jr.
April 20, 2018
In regulations published on April 16, 2018, the Centers for Medicare & Medicaid Services (CMS) issued two new documents containing guidance primarily on the Medicare Advantage (MA) program and on the Medicare prescription drug benefit...
Read More ->